ÂÜÀòÂÒÂ×

Ivan Burkov is a highly experienced professional who has held various roles in the healthcare investment sector. Currently serving as a Junior Partner and Principal at Inkef, Ivan also acts as a Board Director for Ambagon, Draupnir Bio, and Salvia Bioelectronics. In addition, Ivan holds observer roles in companies such as Precirix, Quralis, and NMD Pharma. Ivan has previous experience as a Mentor at the Skolkovo Foundation, a Summer Associate at Forbion, and a Business Development and Innovation Manager at Sanofi. Their educational background includes a PhD in Genetics and an MBA from INSEAD, providing him with a strong foundation in both scientific and business fields.